LifeTech Scientific Past Earnings Performance
Past criteria checks 1/6
LifeTech Scientific has been growing earnings at an average annual rate of 19.8%, while the Medical Equipment industry saw earnings growing at 10.9% annually. Revenues have been growing at an average rate of 17.4% per year. LifeTech Scientific's return on equity is 3.2%, and it has net margins of 20.8%.
Key information
19.8%
Earnings growth rate
19.6%
EPS growth rate
Medical Equipment Industry Growth | 13.7% |
Revenue growth rate | 17.4% |
Return on equity | 3.2% |
Net Margin | 20.8% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Some Confidence Is Lacking In LifeTech Scientific Corporation's (HKG:1302) P/E
Jul 05LifeTech Scientific's (HKG:1302) Soft Earnings Are Actually Better Than They Appear
Apr 25What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You
Dec 25Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled
Nov 28At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?
Nov 03Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)
Aug 17Is There Now An Opportunity In LifeTech Scientific Corporation (HKG:1302)?
Jul 18Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)
May 05Here's What To Make Of LifeTech Scientific's (HKG:1302) Decelerating Rates Of Return
Oct 14There's Been No Shortage Of Growth Recently For LifeTech Scientific's (HKG:1302) Returns On Capital
Jul 15Does LifeTech Scientific (HKG:1302) Deserve A Spot On Your Watchlist?
Jun 30A Look At The Fair Value Of LifeTech Scientific Corporation (HKG:1302)
Jun 15Returns At LifeTech Scientific (HKG:1302) Are On The Way Up
Apr 03Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock
Mar 15Is LifeTech Scientific Corporation (HKG:1302) Potentially Undervalued?
Jan 22Some Investors May Be Worried About LifeTech Scientific's (HKG:1302) Returns On Capital
Dec 19Here's Why I Think LifeTech Scientific (HKG:1302) Might Deserve Your Attention Today
Dec 06Is LifeTech Scientific (HKG:1302) A Risky Investment?
Nov 20An Intrinsic Calculation For LifeTech Scientific Corporation (HKG:1302) Suggests It's 34% Undervalued
Oct 12The Returns On Capital At LifeTech Scientific (HKG:1302) Don't Inspire Confidence
Sep 13Should You Be Adding LifeTech Scientific (HKG:1302) To Your Watchlist Today?
Aug 28What Is LifeTech Scientific Corporation's (HKG:1302) Share Price Doing?
Aug 13LifeTech Scientific's (HKG:1302) Returns On Capital Not Reflecting Well On The Business
Jun 08Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock
May 26Should You Investigate LifeTech Scientific Corporation (HKG:1302) At HK$4.14?
May 11LifeTech Scientific (HKG:1302) Could Easily Take On More Debt
Mar 31Shareholders Are Thrilled That The LifeTech Scientific (HKG:1302) Share Price Increased 274%
Feb 21Do Insiders Own Lots Of Shares In LifeTech Scientific Corporation (HKG:1302)?
Jan 26Does LifeTech Scientific's (HKG:1302) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 13Are Strong Financial Prospects The Force That Is Driving The Momentum In LifeTech Scientific Corporation's HKG:1302) Stock?
Nov 25Revenue & Expenses Breakdown
How LifeTech Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 1,267 | 263 | 415 | 298 |
30 Sep 23 | 1,224 | 297 | 399 | 258 |
30 Jun 23 | 1,182 | 331 | 382 | 219 |
31 Mar 23 | 1,139 | 328 | 365 | 214 |
31 Dec 22 | 1,097 | 325 | 348 | 208 |
30 Sep 22 | 1,058 | 314 | 329 | 195 |
30 Jun 22 | 1,019 | 303 | 311 | 181 |
31 Mar 22 | 972 | 298 | 297 | 164 |
31 Dec 21 | 925 | 292 | 283 | 146 |
30 Sep 21 | 878 | 307 | 320 | 164 |
30 Jun 21 | 830 | 322 | 356 | 183 |
31 Mar 21 | 736 | 269 | 342 | 175 |
31 Dec 20 | 642 | 216 | 327 | 167 |
30 Sep 20 | 638 | 176 | 302 | 150 |
30 Jun 20 | 633 | 136 | 277 | 133 |
31 Mar 20 | 651 | 132 | 288 | 137 |
31 Dec 19 | 669 | 129 | 299 | 141 |
30 Sep 19 | 644 | 138 | 276 | 137 |
30 Jun 19 | 618 | 146 | 252 | 132 |
31 Mar 19 | 588 | 134 | 239 | 124 |
31 Dec 18 | 557 | 121 | 226 | 115 |
30 Sep 18 | 518 | 134 | 196 | 96 |
30 Jun 18 | 480 | 147 | 165 | 76 |
31 Mar 18 | 445 | 155 | 151 | 69 |
31 Dec 17 | 409 | 163 | 138 | 62 |
30 Sep 17 | 391 | 171 | 138 | 61 |
30 Jun 17 | 373 | 178 | 139 | 59 |
31 Mar 17 | 363 | 162 | 136 | 58 |
31 Dec 16 | 353 | 146 | 133 | 58 |
30 Sep 16 | 336 | 201 | 126 | 55 |
30 Jun 16 | 319 | 256 | 119 | 52 |
31 Mar 16 | 315 | 129 | 120 | 50 |
31 Dec 15 | 312 | 2 | 121 | 47 |
30 Sep 15 | 304 | -41 | 123 | 42 |
30 Jun 15 | 296 | -84 | 125 | 38 |
31 Mar 15 | 289 | -83 | 135 | 35 |
31 Dec 14 | 283 | -81 | 145 | 33 |
30 Sep 14 | 280 | -151 | 151 | 35 |
30 Jun 14 | 258 | -209 | 139 | 34 |
31 Mar 14 | 248 | -89 | 130 | 33 |
31 Dec 13 | 231 | -66 | 115 | 31 |
30 Sep 13 | 209 | -53 | 101 | 27 |
Quality Earnings: 1302 has a large one-off loss of CN¥177.9M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: 1302's current net profit margins (20.8%) are lower than last year (29.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1302's earnings have grown by 19.8% per year over the past 5 years.
Accelerating Growth: 1302's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 1302 had negative earnings growth (-19.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.3%).
Return on Equity
High ROE: 1302's Return on Equity (3.2%) is considered low.